Advertisement

The Latest

The Food and Drug Administration has approved the availability of Medtronic's Attain Ability left-heart lead for use with cardiac resynchronization therapy devices for heart failure patients, according to a Medtronic news release.

A new initiative by the Department of Health and Human Service's Agency for Healthcare Research and Quality encourages patients to ask their physicians questions regarding surgery and other aspects of healthcare in an effort to reduce preventable medical errors, according…

Advertisement